Patent · US Active

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

US11441127B2 · kind B2 · utility

1Cited by

3References

16Claims

0Family size

Assignee

University of Georgia Research Foundation, Inc. · US

Inventors

Brian Jordan · Watkinsville, US
Mark W. Jackwood · Watkinsville, US

Key dates

Filing date	Dec 23, 2020
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Dec 30, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/20071
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Attenuated isolates of the Arkansas serotype of infectious bronchitis virus (IBV), including the IBV isolate ArkGA p40 deposited at the ATCC under Patent Designation PTA-126834, and compositions thereof are presented. Methods for administering the isolates or compositions as vaccines to the prevent virulent IBV infection in birds of the order Galliformes are also presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.